Mineralys Therapeutics, Inc. Common Stock Financial Flexibility Index
Mineralys Therapeutics, Inc. Common Stock financial flexibility index. Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Financial Flexibility Index of -0.28x as of June 2026. Free cash flow of $-32.56 Million (operating CF $-32.56 Million minus capex $0.00) represents 0% of total liabilities ($116.94 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mineralys Therapeutics, Inc. Common Stock (2020–2025)
Financial flexibility index of Mineralys Therapeutics, Inc. Common Stock from 2020 to 2025. Historical Financial Flexibility Index trend for Mineralys Therapeutics, Inc. Common Stock across 6 annual periods. Explore Mineralys Therapeutics, Inc. Common Stoc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Mineralys Therapeutics, Inc. Common Stock Financial Flexibility Index by Year (2020–2025)
Mineralys Therapeutics, Inc. Common Stock financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Mineralys Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Mineralys Therapeutics, Inc. Common Stoc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.42x | $-142.40 Million | $-142.42 Million | $15.11 Million | ▲ +17.0% |
| 2024 | -11.35x | $-166.22 Million | $-166.31 Million | $14.65 Million | ▼ -46.6% |
| 2023 | -7.74x | $-81.17 Million | $-81.17 Million | $10.48 Million | ▼ -4318.1% |
| 2022 | -0.18x | $-29.22 Million | $-29.22 Million | $166.71 Million | ▲ +59.0% |
| 2021 | -0.43x | $-14.56 Million | $-14.56 Million | $34.05 Million | ▲ +11.8% |
| 2020 | -0.48x | $-2.46 Million | $-2.46 Million | $5.08 Million | — |